EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): $0.15

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.15. In 2022 the company made an earnings per share (EPS) of $0.15 a decrease over its 2021 EPS that were of $0.18.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	$0.15	-2.18%
2022	$0.15	-17.1%
2021	$0.18	-24.44%
2020	$0.24	20.3%
2019	$0.20	25.58%
2018	$0.16	27.55%
2017	$0.13	21.64%
2016	$0.10	13.57%
2015	$0.09161	39.86%
2014	$0.06550	21.33%
2013	$0.05398	17.7%
2012	$0.04587	25.56%
2011	$0.03653	26.22%
2010	$0.02894	10.3%
2009	$0.02624	57.92%
2008	$0.01661	11.06%
2007	$0.01496	85.81%
2006	$0.008051	87.94%
2005	$0.004284	33.97%
2004	$0.003197	29.78%
2003	$0.002464	19.78%
2002	$0.002057

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions